Compliance to Oseltamivir among Two Populations in Oxfordshire, United Kingdom Affected by Influenza A(H1N1)pdm09, November 2009 - A Waste Water Epidemiology Study

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Singer, Andrew C ^a   Järhult, Josef D ^b   Grabic, Roman ^c,d   Khan, Ghazanfar A ^c   Fedorova, Ganna ^c,d   Fick, Jerker ^c   Lindberg, Richard H ^c   Bowes, Michael J ^a   Olsen, Björn ^b,e   Söderström, Hanna ^c  

^a CENTRE FOR ECOLOGY AND HYDROLOGY   (United Kingdom)

^b UPPSALA UNIVERSITY   (Sweden)

^c UMEÅ UNIVERSITY   (Sweden)

^d UNIVERSITY OF SOUTH BOHEMIA   (Czech Republic)

^e LINNAEUS UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

4 ACETAMIDO 5 AMINO 3 (1 ETHYLPROPOXY) 1 CYCLOHEXENE 1 CARBOXYLIC ACID; OSELTAMIVIR; ANTIVIRUS AGENT; WASTE WATER;

2009 H1N1 INFLUENZA; ARTICLE; DRUG USE; EPIDEMIOLOGICAL DATA; PANDEMIC; PATIENT COMPLIANCE; PREDICTION; UNITED KINGDOM; WASTE WATER; WASTE WATER TREATMENT PLANT; WATER ANALYSIS; WATER SAMPLING; CHEMISTRY; DRUG EFFECTS; HUMAN; INFLUENZA VIRUS A H1N1; INFLUENZA, HUMAN; MEDICATION COMPLIANCE; PHYSIOLOGY; STATISTICS; STATISTICS AND NUMERICAL DATA;

ANTIVIRAL AGENTS; GREAT BRITAIN; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MEDICATION ADHERENCE; OSELTAMIVIR; PANDEMICS; STATISTICS AS TOPIC; WASTE WATER;

EID: 84876162909     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0060221     Document Type: Article

References (35)

1. U.K. Cabinet Office (2012) National Risk Register of Civil Emergencies. 2012 Edition. Available: http://wwwcabinetofficegovuk/sites/default/files/resources/CO_NationalRiskRegister_2012_accpdf. Accessed 1 June 2012.
2. U.K. Cabinet Office (2010) National Risk Register of Civil Emergencies. 2010 Edition. Available: http://wwwcabinetofficegovuk/sites/default/files/resources/nationalriskregister-2010pdf. Accessed 1 June 2012.
3. Singer AC, Colizza V, Schmitt H, Andrews J, Balcan D, et al. (2011) Assessing the ecotoxicologic hazards of a pandemic influenza medical response. Environ Health Perspect 119: 1084-1090.
4. Wallensten A, Oliver I, Lewis D, Harrison S, (2009) Compliance and side effects of prophylactic oseltamivir treatment in a school in South West England. Euro Surveill 14: 19285.
5. Smith A, Coles S, Johnson S, Saldana L, Ihekweazu C, et al. (2009) An outbreak of influenza A(H1N1)v in a boarding school in South East England, May-June 2009. Euro Surveill 14.
6. Kitching A, Roche A, Balasegaram S, Heathcock R, Maguire H, (2009) Oseltamivir Adherence and Side Effects among Children in Three London Schools Affected by Influenza a(H1n1)V, May 2009-an Internet-Based Cross-Sectional Survey. Eurosurveillance 14: 2-5.
7. van Velzen E, Hutchinson S, Penrice G, Ahmed S, McMenamin J, (2011) Compliance to oseltamivir and subsequent occurrence of self-reported adverse drug reactions among nursery and primary school children following exposure to Influenza A(H1N1)v. Scott Med J 56: 120.
8. Strong M, Burrows J, Stedman E, Redgrave P, (2010) Adverse drug effects following oseltamivir mass treatment and prophylaxis in a school outbreak of 2009 pandemic influenza A(H1N1) in June 2009, Sheffield, United Kingdom. Euro Surveill 15: pii/19565.
9. Carrasco LR, Lee VJ, Chen MI, Matchar DB, Thompson JP, et al. (2011) Strategies for antiviral stockpiling for future influenza pandemics: a global epidemic-economic perspective. J R Soc Interface 8: 1307-1313.
10. Kaiser L, Wat C, Mills T, Mahoney P, Ward P, et al. (2003) Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations. Arch Intern Med 163: 1667-1672.
11. Yu H, Liao Q, Yuan Y, Zhou L, Xiang N, et al. (2010) Effectiveness of oseltamivir on disease progression and viral RNA shedding in patients with mild pandemic 2009 influenza A H1N1: opportunistic retrospective study of medical charts in China. BMJ 341: c4779.
12. Slater FR, Singer AC, Turner S, Barr JJ, Bond PL, (2011) Pandemic pharmaceutical dosing effects on wastewater treatment: no adaptation of activated sludge bacteria to degrade the antiviral drug oseltamivir (Tamiflu(R)) and loss of nutrient removal performance. FEMS Microbiol Lett 315: 17-22.
13. Accinelli C, Sacca ML, Fick J, Mencarelli M, Lindberg R, et al. (2010) Dissipation and removal of oseltamivir (Tamiflu) in different aquatic environments. Chemosphere 79: 891-897.
14. Accinelli C, Sacca ML, Batisson I, Fick J, Mencarelli M, et al. (2010) Removal of oseltamivir (Tamiflu) and other selected pharmaceuticals from wastewater using a granular bioplastic formulation entrapping propagules of Phanerochaete chrysosporium. Chemosphere 81: 436-443.
15. Sacca ML, Accinelli C, Fick J, Lindberg R, Olsen B, (2009) Environmental fate of the antiviral drug Tamiflu in two aquatic ecosystems. Chemosphere 75: 28-33.
16. Fick J, Lindberg RH, Tysklind M, Haemig PD, Waldenstrom J, et al. (2007) Antiviral Oseltamivir Is not Removed or Degraded in Normal Sewage Water Treatment: Implications for Development of Resistance by Influenza A Virus. PLoS ONE 2: e986.
17. Prasse C, Schlusener MP, Schulz R, Ternes TA, (2010) Antiviral drugs in wastewater and surface waters: a new pharmaceutical class of environmental relevance? Environ Sci Technol 44: 1728-1735.
18. Soderstrom H, Jarhult JD, Olsen B, Lindberg RH, Tanaka H, et al. (2009) Detection of the antiviral drug oseltamivir in aquatic environments. PLoS ONE 4: e6064.
19. Leknes H, Sturtzel IE, Dye C, (2012) Environmental release of oseltamivir from a Norwegian sewage treatment plant during the 2009 influenza A (H1N1) pandemic. Sci Total Environ 414: 632-638.
20. Singer AC, Howard BM, Johnson AC, Knowles CJ, Jackman S, et al. (2008) Meeting report: risk assessment of tamiflu use under pandemic conditions. Environ Health Perspect 116: 1563-1567.
21. van Nuijs AL, Abdellati K, Bervoets L, Blust R, Jorens PG, et al. (2012) The stability of illicit drugs and metabolites in wastewater, an important issue for sewage epidemiology? J Hazard Mater 239-240: 19-23.
22. Brewer AJ, Ort C, Banta-Green CJ, Berset JD, Field JA, (2012) Normalized diurnal and between-day trends in illicit and legal drug loads that account for changes in population. Environ Sci Technol 46: 8305-8314.
23. Azuma T, Nakada N, Yamashita N, Tanaka H (2012) Synchronous Dynamics of Observed and Predicted Values of Anti-influenza drugs in Environmental Waters during a Seasonal Influenza Outbreak. Environ Sci Technol.
24. Health Protection Agency (HPA) (2010) Epidemiological report of pandemic (H1N1) 2009 in the UK (April 2009 - May 2010). Available: http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1284475321350. Accessed 1 June 2012.
25. World Health Organization (WHO) (2010) WHO recommendations for the post-pandemic period: Pandemic (H1N1) 2009 briefing note 23. Available: http://www.who.int/csr/disease/swineflu/notes/briefing_20100810/en/. Accessed 1 June 2012.
26. TuTiempo.net (2009) Climate: Benson (November, 2009). Available: http://www.tutiempo.net/en/Climate/Benson/11-2009/36580.htm. Accessed 26 October 2012.
27. Khan GA, Lindberg R, Grabic R, Fick J, (2012) The development and application of a system for simultaneously determining anti-infectives and nasal decongestants using on-line solid-phase extraction and liquid chromatography-tandem mass spectrometry. J Pharm Biomed Anal 66: 24-32.
28. Rogers S, Sedghi A (2011) Swine flu data in the UK: see how bad cases are where you live. Guardian. Available: http://www.guardian.co.uk/news/datablog/2011/jan/06/swine-flu-data-uk#data. Accessed 1 June 2012.
29. Singer AC, Nunn MA, Gould EA, Johnson AC, (2007) Potential risks associated with the widespread use of Tamiflu. Environmental Health Perspectives 115: 102-106.
30. Ort C, Lawrence MG, Reungoat J, Mueller JF, (2010) Sampling for PPCPs in wastewater systems: comparison of different sampling modes and optimization strategies. Environ Sci Technol 44: 6289-6296.
31. Tilston NL, Eames KT, Paolotti D, Ealden T, Edmunds WJ, (2010) Internet-based surveillance of Influenza-like-illness in the UK during the 2009 H1N1 influenza pandemic. BMC Public Health 10: 650.
32. Brooks-Pollock E, Tilston N, Edmunds WJ, Eames KT, (2011) Using an online survey of healthcare-seeking behaviour to estimate the magnitude and severity of the 2009 H1N1v influenza epidemic in England. BMC Infect Dis 11: 68.
33. Ort C, Gujer W, (2006) Sampling for representative micropollutant loads in sewer systems. Water Sci Technol 54: 169-176.
34. Straub JO, (2009) An environmental risk assessment for oseltamivir (Tamiflu®) for sewage works and surface waters under seasonal-influenza- and pandemic-use conditions. Ecotoxicology and Environmental Safety 72: 1625-1634.
35. Takanami R, Ozaki H, Giri RR, Taniguchi S, Hayashi S, (2012) Antiviral Drugs Zanamivir and Oseltamivir Found in Wastewater and Surface Water in Osaka, Japan. Journal of Water and Environment Technology 10: 57-68.